BENITEC BIOPHARMA INC. (BNTC) Net margin 2019–2023
BENITEC BIOPHARMA INC. (BNTC) net profit margin by fiscal year — reported net income divided by reported revenue.
-26082.7%FY2023 · since FY2019: 21.4% → -26082.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -26082.7% | -1140.2 pp |
| FY2022 | -24942.5% | -1413.7 pp |
| FY2021 | -23528.8% | -15417.0 pp |
| FY2020 | -8111.8% | -8133.2 pp |
| FY2019 | 21.4% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More BNTC financial trends
BNTC RevenueBNTC Net incomeBNTC Gross profitBNTC Gross marginBNTC Operating incomeBNTC Operating marginBNTC Operating cash flowBNTC Free cash flowBNTC Capital expendituresBNTC Return on equityBNTC Stock buybacksBNTC Dividends paidBNTC Total assetsBNTC Total liabilitiesBNTC Shareholders’ equityBNTC overview →